Investing Experts Making money in biotech stocks
8 snips
Oct 9, 2025 In this discussion, Jonathan Faison, founder of the ROTY Biotech Community and biotech investing strategist, shares his insights on trading in the biotech sector. He reveals different investment strategies, including theme-based trading and managing sector risk. Jonathan emphasizes the importance of focusing on late-stage companies and offers a fascinating case study on Syndax Pharmaceuticals. He also discusses navigating regulatory risks and highlights Geron as a promising undervalued biotech with great potential. Tune in for his expert advice!
AI Snips
Chapters
Transcript
Episode notes
Size Binary Bets For Worst-Case Losses
- Size binary-event bets so a catastrophic loss won't derail your portfolio.
- Ask whether you can accept losing 80–90% of that position before placing the trade.
Regulatory Tailwinds In Rare Disease
- Rare disease trials often enjoy regulatory tailwinds through single-arm approvals.
- Those efficiencies lower cash burn and speed time-to-market for promising drugs.
Keep A Trade Log
- Keep a trade log to learn systematically from winners and losers.
- Replicate strategies that work and avoid setups that repeatedly fail for you.